...
首页> 外文期刊>Scientific reports. >Repair of osteochondral defects with in vitro engineered cartilage based on autologous bone marrow stromal cells in a swine model
【24h】

Repair of osteochondral defects with in vitro engineered cartilage based on autologous bone marrow stromal cells in a swine model

机译:基于自体骨髓基质细胞在猪模型中的体外工程软骨修复骨质色神经缺陷

获取原文

摘要

Functional reconstruction of large osteochondral defects is always a major challenge in articular surgery. Some studies have reported the feasibility of repairing articular osteochondral defects using bone marrow stromal cells (BMSCs) and biodegradable scaffolds. However, no significant breakthroughs have been achieved in clinical translation due to the instability of in vivo cartilage regeneration based on direct cell-scaffold construct implantation. To overcome the disadvantages of direct cell-scaffold construct implantation, the current study proposed an in vitro cartilage regeneration strategy, providing relatively mature cartilage-like tissue with superior mechanical properties. Our strategy involved in vitro cartilage engineering, repair of osteochondral defects, and evaluation of in vivo repair efficacy. The results demonstrated that BMSC engineered cartilage in vitro (BEC-vitro) presented a time-depended maturation process. The implantation of BEC-vitro alone could successfully realize tissue-specific repair of osteochondral defects with both cartilage and subchondral bone. Furthermore, the maturity level of BEC-vitro had significant influence on the repaired results. These results indicated that in vitro cartilage regeneration using BMSCs is a promising strategy for functional reconstruction of osteochondral defect, thus promoting the clinical translation of cartilage regeneration techniques incorporating BMSCs.
机译:大型骨缺陷的功能重建始终是关节手术中的主要挑战。一些研究报告说,使用骨髓基质细胞(BMSCs)和可生物降解支架修复关节骨质缺陷的可行性。然而,由于基于直接细胞 - 支架构建植入的体内软骨再生,临床翻译方面没有显着突破。为了克服直接细胞支架构建植入植入的缺点,目前的研究提出了一种体外软骨再生策略,提供相对成熟的软骨状组织,具有优异的机械性能。我们的策略涉及体外软骨工程,维修骨缺陷,以及体内修复疗效的评价。结果表明,BMSC工程化软骨(BEC-体)呈现了时间依赖的成熟过程。单独的BEC-FIVRO的植入可以成功地实现软骨和子骨髓骨骼的组织特异性修复骨质色神经缺陷。此外,Bec-体外的成熟水平对修复结果产生了显着影响。这些结果表明,使用BMSC的体外软骨再生是骨质色神经缺陷功能重建的有希望的策略,从而促进包含BMSCs的软骨再生技术的临床翻译。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号